CME Group Inc. (NASDAQ:CME) Shares Bought by Diversify Wealth Management LLC

Diversify Wealth Management LLC increased its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 33.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 20,238 shares of the financial services provider's stock after acquiring an additional 5,074 shares during the quarter. Diversify Wealth Management LLC's holdings in CME Group were worth $5,512,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. Heartland Bank & Trust Co acquired a new position in shares of CME Group in the 1st quarter valued at $377,000. Catalyst Capital Advisors LLC boosted its holdings in shares of CME Group by 256.9% in the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after purchasing an additional 2,636 shares during the last quarter. OMNI 360 Wealth Inc. acquired a new position in shares of CME Group in the 1st quarter valued at $367,000. Aspire Growth Partners LLC acquired a new position in shares of CME Group in the 4th quarter valued at $548,000. Finally, First Citizens Bank & Trust Co. boosted its holdings in shares of CME Group by 3.4% in the 1st quarter. First Citizens Bank & Trust Co. now owns 43,135 shares of the financial services provider's stock valued at $11,443,000 after purchasing an additional 1,408 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Stock Up 0.7%

CME Group stock traded up $1.98 during midday trading on Monday, hitting $277.06. 1,470,360 shares of the stock were exchanged, compared to its average volume of 2,178,350. CME Group Inc. has a 1 year low of $193.25 and a 1 year high of $290.79. The firm has a market cap of $99.84 billion, a P/E ratio of 27.87, a P/E/G ratio of 4.45 and a beta of 0.44. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a 50 day moving average price of $276.58 and a two-hundred day moving average price of $259.51.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company's revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.50 EPS. On average, sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.80%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's payout ratio is currently 50.30%.

Wall Street Analyst Weigh In

CME has been the topic of a number of research analyst reports. Royal Bank Of Canada reiterated a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a report on Thursday, April 3rd. Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a report on Thursday, April 24th. UBS Group lifted their target price on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a report on Friday, April 25th. Oppenheimer lifted their target price on shares of CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Finally, Citigroup lifted their target price on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $260.93.

Insider Buying and Selling

In other news, Director Daniel G. Kaye sold 500 shares of the business's stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the completion of the sale, the director owned 3,668 shares of the company's stock, valued at approximately $1,035,916.56. The trade was a 12.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Jonathan L. Marcus sold 390 shares of CME Group stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $277.50, for a total transaction of $108,225.00. Following the completion of the transaction, the general counsel directly owned 6,708 shares of the company's stock, valued at $1,861,470. This trade represents a 5.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,400 shares of company stock worth $3,680,610. 0.30% of the stock is currently owned by insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.